Ameriprise’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.08M Buy
264,092
+179,108
+211% +$2.77M ﹤0.01% 2505
2025
Q1
$1.26M Buy
84,984
+19,861
+30% +$295K ﹤0.01% 3082
2024
Q4
$862K Sell
65,123
-9,169
-12% -$121K ﹤0.01% 3285
2024
Q3
$1.06M Buy
74,292
+19,704
+36% +$280K ﹤0.01% 3189
2024
Q2
$706K Sell
54,588
-31,850
-37% -$412K ﹤0.01% 3311
2024
Q1
$1.2M Buy
86,438
+4,945
+6% +$68.7K ﹤0.01% 3096
2023
Q4
$1.16M Buy
81,493
+1,030
+1% +$14.7K ﹤0.01% 3126
2023
Q3
$1.24M Buy
80,463
+4,353
+6% +$67.3K ﹤0.01% 3046
2023
Q2
$1.2M Buy
76,110
+3,205
+4% +$50.4K ﹤0.01% 3095
2023
Q1
$1.2M Sell
72,905
-25,918
-26% -$427K ﹤0.01% 3072
2022
Q4
$1.54M Sell
98,823
-12,959
-12% -$202K ﹤0.01% 2920
2022
Q3
$1.45M Buy
111,782
+51,917
+87% +$673K ﹤0.01% 2942
2022
Q2
$840K Sell
59,865
-20,818
-26% -$292K ﹤0.01% 3189
2022
Q1
$1.16M Buy
80,683
+16,097
+25% +$230K ﹤0.01% 3148
2021
Q4
$885K Sell
64,586
-8,316
-11% -$114K ﹤0.01% 3310
2021
Q3
$1.19M Buy
72,902
+10,637
+17% +$174K ﹤0.01% 3092
2021
Q2
$1.05M Buy
62,265
+1,508
+2% +$25.4K ﹤0.01% 3202
2021
Q1
$1.12M Buy
60,757
+16,482
+37% +$302K ﹤0.01% 3101
2020
Q4
$807K Sell
44,275
-13,750
-24% -$251K ﹤0.01% 3177
2020
Q3
$1.04M Sell
58,025
-125,318
-68% -$2.24M ﹤0.01% 2951
2020
Q2
$3.29M Buy
183,343
+137,989
+304% +$2.47M ﹤0.01% 2345
2020
Q1
$688K Sell
45,354
-430
-0.9% -$6.52K ﹤0.01% 2985
2019
Q4
$904K Sell
45,784
-3,749
-8% -$74K ﹤0.01% 3099
2019
Q3
$851K Sell
49,533
-5,219
-10% -$89.7K ﹤0.01% 3082
2019
Q2
$969K Sell
54,752
-70,307
-56% -$1.24M ﹤0.01% 3076
2019
Q1
$2.55M Buy
125,059
+12,069
+11% +$246K ﹤0.01% 2623
2018
Q4
$1.9M Buy
+112,990
New +$1.9M ﹤0.01% 2666
2017
Q1
Sell
-25,528
Closed -$530K 3661
2016
Q4
$530K Buy
25,528
+15,347
+151% +$319K ﹤0.01% 3255
2016
Q3
$244K Sell
10,181
-3,232
-24% -$77.5K ﹤0.01% 3484
2016
Q2
$289K Sell
13,413
-572
-4% -$12.3K ﹤0.01% 3377
2016
Q1
$319K Sell
13,985
-3,253
-19% -$74.2K ﹤0.01% 3327
2015
Q4
$432K Buy
17,238
+1,431
+9% +$35.9K ﹤0.01% 3309
2015
Q3
$346K Sell
15,807
-1,089
-6% -$23.8K ﹤0.01% 3395
2015
Q2
$414K Sell
16,896
-1,192
-7% -$29.2K ﹤0.01% 3483
2015
Q1
$452K Buy
18,088
+1,650
+10% +$41.2K ﹤0.01% 3249
2014
Q4
$343K Buy
16,438
+9,741
+145% +$203K ﹤0.01% 3276
2014
Q3
$146K Sell
6,697
-1,061
-14% -$23.1K ﹤0.01% 3520
2014
Q2
$180K Sell
7,758
-875
-10% -$20.3K ﹤0.01% 3363
2014
Q1
$205K Sell
8,633
-155
-2% -$3.68K ﹤0.01% 3234
2013
Q4
$202K Buy
8,788
+835
+10% +$19.2K ﹤0.01% 3138
2013
Q3
$188K Buy
7,953
+1,620
+26% +$38.3K ﹤0.01% 3207
2013
Q2
$146K Buy
+6,333
New +$146K ﹤0.01% 3218